Related Experiment Video
Updated: Apr 26, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Hyperthermia inhibited the migration of tongue squamous cell carcinoma through TWIST2
Ya-ling Tang1, Jian Jiang, Jeffrey Liu
1State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, (Sichuan University), Chengdu, Sichuan, China; Department of Oral Pathology, West China Hospital of Stomatology, (Sichuan University), Chengdu, Sichuan, China.
Background:
Hyperthermia has been shown promising in the treatment of head and neck squamous cell carcinoma (HNSCC); however, the mechanism underlying hyperthermia reducing tumor metastasis is poorly elucidated. TWIST2, an important transcription factor of epithelial-mesenchymal transition (EMT), plays a critical role in the tumor progression and metastasis. The role of TWIST2 in tongue squamous cell carcinoma (TSCC) and its association with hyperthermia still have not been reported.
Method:
The correlations between TWIST2 expression and the clinical-pathologic characteristics of 89 patients with TSCC were evaluated by immunohistochemical staining. TSCC cell lines transfected with siRNA against TWIST2 were heated for 40 min at 42.5°C, and the migration capability of cells was examined by migration assay. Xenograft tumors in nude mice were treated by hyperthermia, and TWIST2 expression was measured.
Results:
Our data showed that TWIST2 expression was associated with the metastasis of human TSCC. In Tca8113 and Cal-27 cells, TWIST2-siRNA treatment can reduce cell migration ability and has no effect on the cell proliferation and apoptosis. Hyperthermia can decrease the level of TWIST2 in TSCC and inhibit the migration of cells.
Conclusions:
This demonstrated that hyperthermia might decrease the migration of Tca8113 and Cal-27 cells by reducing TWIST2 expression. Altogether, these findings suggest an as yet undescribed link between TWIST2 and hyperthermia in TSCC.
Insights
Hyperthermia therapy may reduce tongue squamous cell carcinoma (TSCC) metastasis by lowering TWIST2 expression, a key factor in tumor cell migration. This study explores the link between hyperthermia, TWIST2, and TSCC progression.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Hyperthermia shows promise for head and neck squamous cell carcinoma (HNSCC) treatment, but its mechanism in reducing tumor metastasis is unclear.
- TWIST2, a transcription factor crucial for epithelial-mesenchymal transition (EMT), significantly influences tumor progression and metastasis.
- The specific role of TWIST2 in tongue squamous cell carcinoma (TSCC) and its interaction with hyperthermia remain uninvestigated.
Purpose of the Study:
- To investigate the role of TWIST2 in TSCC metastasis.
- To explore the effect of hyperthermia on TWIST2 expression and TSCC cell migration.
- To elucidate the potential mechanism by which hyperthermia impacts TSCC metastasis.
Main Methods:
- Immunohistochemical staining assessed TWIST2 expression in 89 TSCC patients.
- TSCC cell lines were treated with TWIST2-siRNA and subjected to hyperthermia (42.5°C for 40 min) to evaluate migration.
- Xenograft tumors in nude mice were treated with hyperthermia, and TWIST2 expression was measured.
Main Results:
- TWIST2 expression correlated with metastasis in human TSCC.
- TWIST2-siRNA treatment reduced migration in Tca8113 and Cal-27 cells without affecting proliferation or apoptosis.
- Hyperthermia decreased TWIST2 levels in TSCC and inhibited cell migration.
Conclusions:
- Hyperthermia may reduce TSCC cell migration by downregulating TWIST2 expression.
- These findings reveal a novel association between TWIST2 and hyperthermia in TSCC.
- This research provides insights into hyperthermia's therapeutic potential for TSCC by targeting TWIST2-mediated metastasis.
More Related Videos
Related Concept Videos
Cancer Cell Migration through Invadopodia
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Hyperthyroidism II: Pathophysiology
Chemotaxis and Direction of Cell Migration

